CCL28



CCL28

S1SS1E2EE2A3AA3I4II4L5LL5P6PP6I7II7A8AA8S9SS9S10SS10C11CC11C12CC12T13TT13E14EE14V15VV15S16SS16H17HH17H18HH18I19II19S20SS20R21RR21R22RR22L23LL23L24LL24E25EE25R26RR26V27VV27N28NN28M29MM29C30CC30R31RR31I32II32Q33QQ33R34RR34A35AA35D36DD36G37GG37D38DD38C39CC39D40DD40L41LL41A42AA42A43AA43V44VV44I45II45L46LL46H47HH47... and 61 more residue(s)...... and 61 more residue(s)

SMILES None
InChIKey None
Sequence SEAILPIASSCCTEVSHHISRRLLERVNMCRIQRADGDCDLAAVILHVKRRRICVSPHNHTVKQWMKVQAAKKNGKGNVCHRKKHHGKRNSNRAHQGKHETYGHKTPY

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections



No bioactivity data available.

CCL28

S1SS1E2EE2A3AA3I4II4L5LL5P6PP6I7II7A8AA8S9SS9S10SS10C11CC11C12CC12T13TT13E14EE14V15VV15S16SS16H17HH17H18HH18I19II19S20SS20R21RR21R22RR22L23LL23L24LL24E25EE25R26RR26V27VV27N28NN28M29MM29C30CC30R31RR31I32II32Q33QQ33R34RR34A35AA35D36DD36G37GG37D38DD38C39CC39D40DD40L41LL41A42AA42A43AA43V44VV44I45II45L46LL46H47HH47... and 61 more residue(s)...... and 61 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections



Compound is not listed as a drug.